:max_bytes(150000):strip_icc()/06-StressTestinganETFPortfolio-06d4f34a80594f06b4dee79a6fa2fc4b.png?#)
:max_bytes(150000):strip_icc()/02_Beyond60_40BuildingaMulti-AssetETFPortfolioforStructuralUncertainty-58ddfdc3daa042ec84bdb410fc1a652e.png?#)
Growth in the post-Lenalidomide era for pharma stocks
Pharma companies face declining profits as the lenalidomide opportunity fades, impacting future growth and margins.
Pharma companies face declining profits as the lenalidomide opportunity fades, impacting future growth and margins.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
